Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
470.59
+1.21 (0.26%)
At close: Mar 6, 2026, 4:00 PM EST
469.60
-0.99 (-0.21%)
After-hours: Mar 6, 2026, 6:43 PM EST
Medpace Holdings Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Medpace Holdings stock have an average target of 498.25, with a low estimate of 305 and a high estimate of 655. The average target predicts an increase of 5.88% from the current stock price of 470.59.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medpace Holdings stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 7 | 8 | 8 | 8 | 8 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 1 | 1 |
| Total | 11 | 12 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell → Hold Upgrades $500 | Sell → Hold | Upgrades | $500 | +6.25% | Mar 6, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $522 | Buy | Initiates | $522 | +10.92% | Mar 3, 2026 |
| TD Cowen | TD Cowen | Strong Sell → Hold Upgrades $462 → $419 | Strong Sell → Hold | Upgrades | $462 → $419 | -10.96% | Feb 18, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $560 | Hold → Strong Buy | Upgrades | $560 | +19.00% | Feb 13, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $555 → $539 | Hold | Maintains | $555 → $539 | +14.54% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
2.86B
from 2.53B
Increased by 13.11%
Revenue Next Year
3.08B
from 2.86B
Increased by 7.51%
EPS This Year
17.43
from 15.28
Increased by 14.09%
EPS Next Year
19.36
from 17.43
Increased by 11.03%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.0B | 3.4B | |||
| Avg | 2.9B | 3.1B | |||
| Low | 2.7B | 2.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.5% | 19.6% | |||
| Avg | 13.1% | 7.5% | |||
| Low | 6.3% | -7.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.20 | 20.44 | |||
| Avg | 17.43 | 19.36 | |||
| Low | 16.56 | 17.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.1% | 17.3% | |||
| Avg | 14.1% | 11.0% | |||
| Low | 8.4% | 3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.